MilliporeSigma and the University of Oxford’s Jenner Institute will develop more cost-effective vaccine manufacturing processes. (Pixabay)
MilliporeSigma, Merck KGaA’s life science service provider, is teaming with the University of Oxford’s vaccine-focused research body, the Jenner Institute, to develop more cost-effective vaccine manufacturing processes.
The partnership aims to improve the production of vaccines that use adenovirus as vectors. With 30 years’ experience in viral vector manufacturing, MilliporeSigma will contribute its products, systems and technologies for the pair to develop a closed manufacturing process that happens in a cleanroom to minimize contamination and ensure product safety.